Healthpeak Properties’ (DOC) “Outperform” Rating Reaffirmed at Wedbush

Healthpeak Properties (NYSE:DOC)‘s stock had its “outperform” rating reissued by analysts at Wedbush in a report released on Friday,Benzinga reports. They presently have a $24.00 price target on the real estate investment trust’s stock. Wedbush’s price target points to a potential upside of 32.30% from the company’s current price. Wedbush also issued estimates for Healthpeak Properties’ Q3 2025 earnings at $0.46 EPS, Q4 2025 earnings at $0.47 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.49 EPS, Q3 2026 earnings at $0.49 EPS and Q4 2026 earnings at $0.50 EPS.

A number of other analysts also recently commented on DOC. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Saturday, March 22nd. Robert W. Baird decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Finally, Scotiabank decreased their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Four analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $23.83.

Healthpeak Properties Trading Down 0.2 %

NYSE:DOC opened at $18.14 on Friday. Healthpeak Properties has a 52 week low of $17.33 and a 52 week high of $23.26. The firm has a 50-day moving average price of $19.79 and a two-hundred day moving average price of $20.82. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market cap of $12.69 billion, a price-to-earnings ratio of 51.83, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02.

Hedge Funds Weigh In On Healthpeak Properties

Large investors have recently made changes to their positions in the stock. Mizuho Bank Ltd. bought a new stake in shares of Healthpeak Properties during the 4th quarter valued at $28,000. Harvest Fund Management Co. Ltd bought a new stake in shares of Healthpeak Properties during the fourth quarter valued at about $30,000. Future Financial Wealth Managment LLC bought a new stake in shares of Healthpeak Properties during the first quarter valued at about $30,000. Covestor Ltd lifted its holdings in shares of Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 1,152 shares in the last quarter. Finally, Continuum Advisory LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $44,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.